Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Design, synthesis, molecular docking, and in vitro α-glucosidase inhibitory activities of novel 3-amino-2,4-diarylbenzo[4,5]imidazo[1,2-a]pyrimidines against yeast and rat α-glucosidase.
Peytam F, Takalloobanafshi G, Saadattalab T, Norouzbahari M, Emamgholipour Z, Moghimi S, Firoozpour L, Bijanzadeh HR, Faramarzi MA, Mojtabavi S, Rashidi-Ranjbar P, Karima S, Pakraad R, Foroumadi A. Peytam F, et al. Among authors: bijanzadeh hr. Sci Rep. 2021 Jun 7;11(1):11911. doi: 10.1038/s41598-021-91473-z. Sci Rep. 2021. PMID: 34099819 Free PMC article.
New 6-amino-pyrido[2,3-d]pyrimidine-2,4-diones as novel agents to treat type 2 diabetes: A simple and efficient synthesis, α-glucosidase inhibition, molecular modeling and kinetic study.
Adib M, Peytam F, Rahmanian-Jazi M, Mahernia S, Bijanzadeh HR, Jahani M, Mohammadi-Khanaposhtani M, Imanparast S, Faramarzi MA, Mahdavi M, Larijani B. Adib M, et al. Among authors: bijanzadeh hr. Eur J Med Chem. 2018 Jul 15;155:353-363. doi: 10.1016/j.ejmech.2018.05.046. Epub 2018 May 29. Eur J Med Chem. 2018. PMID: 29902721
Quinazolin-4(3H)-one based agents bearing thiadiazole-urea: Synthesis and evaluation of anti-proliferative and antiangiogenic activity.
Faraji A, Motahari R, Hasanvand Z, Oghabi Bakhshaiesh T, Toolabi M, Moghimi S, Firoozpour L, Boshagh MA, Rahmani R, Ketabforoosh SHME, Bijanzadeh HR, Esmaeili R, Foroumadi A. Faraji A, et al. Among authors: bijanzadeh hr. Bioorg Chem. 2021 Mar;108:104553. doi: 10.1016/j.bioorg.2020.104553. Epub 2020 Dec 13. Bioorg Chem. 2021. PMID: 33376012
Thienopyrimidine-based agents bearing diphenylurea: Design, synthesis, and evaluation of antiproliferative and antiangiogenic activity.
Mohammadian E, Oghabi Bakhshaiesh T, Jouyban A, Nazeri E, Hasanvand Z, Moghimi S, Motahari R, Firoozpour L, Bijanzadeh H, Alizadeh Sani M, Hosseinzadeh E, Esmaeili R, Foroumadi A. Mohammadian E, et al. Arch Pharm (Weinheim). 2023 Mar;356(3):e2200349. doi: 10.1002/ardp.202200349. Epub 2022 Nov 21. Arch Pharm (Weinheim). 2023. PMID: 36408898
Imidazo[1,2-a]quinazolines as novel, potent EGFR-TK inhibitors: Design, synthesis, bioactivity evaluation, and in silico studies.
Hasanvand Z, Oghabi Bakhshaiesh T, Peytam F, Firoozpour L, Hosseinzadeh E, Motahari R, Moghimi S, Nazeri E, Toolabi M, Momeni F, Bijanzadeh H, Khalaj A, Baratte B, Josselin B, Robert T, Bach S, Esmaeili R, Foroumadi A. Hasanvand Z, et al. Bioorg Chem. 2023 Apr;133:106383. doi: 10.1016/j.bioorg.2023.106383. Epub 2023 Jan 20. Bioorg Chem. 2023. PMID: 36764231
Synthesis of Novel Peptides Using Unusual Amino Acids.
Talaei B, Fathi Vavsari V, Balalaie S, Arabanian A, Bijanzadeh HR. Talaei B, et al. Among authors: bijanzadeh hr. Iran J Pharm Res. 2020 Summer;19(3):370-382. doi: 10.22037/ijpr.2020.113827.14509. Iran J Pharm Res. 2020. PMID: 33680037 Free PMC article.
39 results